Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
80.85
-0.16 (-0.20%)
At close: Feb 19, 2026, 4:00 PM EST
80.85
0.00 (0.00%)
After-hours: Feb 19, 2026, 4:10 PM EST
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $225.23 million as of February 19, 2026. Its market cap has increased by 957.42% in one year.
Market Cap
225.23M
Enterprise Value
205.92M
1-Year Change
957.42%
Ranking
Category
Stock Price
$80.85
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $228.30M to $225.23M, a decrease of -1.34%. That is a compound annual growth rate of -0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 205.60M | 75.13% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 199.42M |
| Humacyte | 194.93M |
| Tonix Pharmaceuticals Holding | 193.70M |
| Voyager Therapeutics | 188.48M |
| Ovid Therapeutics | 184.86M |
| Prelude Therapeutics | 183.75M |
| SAB Biotherapeutics | 183.29M |
| C4 Therapeutics | 183.17M |